NUS

+ Watchlist + Portfolio

Nu Skin Enterprises, Inc.

Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $4.55
52-Week Range: $4.45 – $11.67
Market Cap: $224.40M
P/E (TTM): —
EPS (TTM): -4.51
Dividend Yield: 5.21%

Advanced Metrics

Price/Book: 0.41
PEG Ratio: 0.78
Return on Equity: -32.53%
Return on Assets: 3.43%
Gross Margin: 69.19%
Operating Margin: 6.11%
Profit Margin: -15.73%
Current Ratio: 1.98
Debt/Equity: 0.53
Total Debt: $288.10M
Free Cash Flow: $35.20M
Revenue Growth: -17.10%
Earnings Growth: —
Enterprise Value: $321.11M

NUS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.23B	$1.97B	$1.73B	$1.49B
Cost of Revenue	$630.91M	$611.85M	$550.23M	$453.76M
Gross Profit	$1.59B	$1.36B	$1.18B	$1.03B
Selling, General & Admin	$1.44B	$1.29B	$1.13B	$940.52M
Operating Expenses	$1.44B	$1.29B	$1.13B	$940.52M
Operating Income	$159.34M	$68.06M	$50.77M	$90.88M
EBITDA	$174.97M	$123.06M	-$78.83M	$262.41M
Pretax Income	$88.97M	$26.58M	-$175.05M	$196.20M
Income Tax	-$15.81M	$17.98M	-$28.46M	$35.99M
Net Income	$104.78M	$8.60M	-$146.59M	$160.20M
Diluted EPS	2.07	0.17	-2.95	3.18
Diluted Shares	50.52M	49.86M	49.66M	50.30M

NUS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$264.73M	$256.06M	$186.88M	$238.63M
Receivables	$47.36M	$58.70M	$50.78M	$39.54M
Inventory	$346.18M	$279.98M	$190.24M	$178.64M
Current Assets	$759.87M	$701.87M	$538.60M	$547.70M
Total Assets	$1.82B	$1.81B	$1.47B	$1.41B
Current Liabilities	$359.24M	$328.87M	$296.61M	$263.73M
Long-Term Debt	$377.47M	$478.04M	$363.61M	$204.19M
Total Debt	$520.52M	$607.33M	$478.23M	$306.61M
Total Liabilities	$923.67M	$986.66M	$817.46M	$600.07M
Retained Earnings	$1.94B	$1.87B	$1.71B	$1.86B
Shareholders' Equity	$897.30M	$821.97M	$651.46M	$805.24M
Working Capital	$400.63M	$373.00M	$241.99M	$283.96M
Net Debt	$137.74M	$246.98M	$206.73M	—

NUS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$108.06M	$118.64M	$111.74M	$80.29M
Capital Expenditure	-$59.06M	-$58.49M	-$41.58M	-$34.28M
Free Cash Flow	$49.01M	$60.15M	$70.16M	$46.01M
Depreciation & Amortisation	$72.51M	$70.92M	$69.81M	$52.26M
Stock-Based Compensation	$12.37M	$15.65M	$14.82M	$24.11M
Investing Cash Flow	-$67.08M	-$134.50M	-$37.96M	$170.66M
Financing Cash Flow	-$99.50M	$10.73M	-$133.18M	-$202.40M
Dividends Paid	-$77.02M	-$77.62M	-$11.93M	-$11.83M
Share Repurchases	-$70.05M	-$13.01M	$0.00	-$20.04M
Net Change in Cash	-$58.52M	-$5.13M	-$59.40M	$48.54M

NUS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$364.49M	$386.14M	$364.21M	$370.32M	$320.61M	$320.11M
Cost of Revenue	$117.53M	$120.41M	$107.49M	$108.34M	$106.14M	$101.79M
Gross Profit	$246.96M	$265.73M	$256.72M	$261.98M	$214.46M	$218.32M
Selling, General & Admin	$231.75M	$234.95M	$235.08M	$238.74M	$208.60M	$198.77M
Operating Expenses	$231.75M	$234.95M	$235.08M	$238.74M	$208.60M	$198.77M
Operating Income	$15.21M	$30.78M	$21.64M	$23.24M	$5.87M	$19.56M
EBITDA	$152.09M	$42.99M	$32.23M	$35.10M	$19.19M	-$47.20M
Pretax Income	$134.60M	$27.41M	$15.99M	$18.19M	$2.60M	-$63.17M
Income Tax	$27.09M	$6.29M	-$1.08M	$3.70M	$763.00K	$186.62M
Net Income	$107.52M	$21.12M	$17.08M	$14.49M	$1.84M	-$249.80M
Diluted EPS	2.14	0.43	0.34	0.29	0.04	-5.14
Diluted Shares	50.33M	49.50M	50.31M	49.91M	49.42M	48.60M

NUS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$203.77M	$264.16M	$251.79M	$238.63M	$198.65M	$189.64M
Receivables	$56.58M	$59.70M	$48.89M	$39.54M	$45.01M	$48.90M
Inventory	$188.78M	$180.38M	$178.53M	$178.64M	$178.60M	$191.50M
Current Assets	$524.86M	$571.55M	$548.14M	$547.70M	$522.89M	$508.15M
Total Assets	$1.39B	$1.44B	$1.42B	$1.41B	$1.38B	$1.12B
Current Liabilities	$260.30M	$283.91M	$254.44M	$263.73M	$257.00M	$256.35M
Long-Term Debt	$218.76M	$213.90M	$209.04M	$204.19M	$203.59M	$193.66M
Total Debt	$300.71M	$310.74M	$291.43M	$306.61M	$277.61M	$263.74M
Total Liabilities	$637.44M	$655.94M	$624.61M	$600.07M	$582.71M	$578.79M
Retained Earnings	$1.82B	$1.83B	$1.85B	$1.86B	$1.86B	$1.61B
Shareholders' Equity	$753.97M	$787.75M	$799.79M	$805.24M	$794.09M	$542.74M
Working Capital	$264.56M	$287.65M	$293.71M	$283.96M	$265.89M	$251.80M
Net Debt	$34.99M	—	—	—	$24.94M	$24.02M

NUS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$389.00K	$35.80M	$27.48M	$16.62M	-$3.92M	$10.63M
Capital Expenditure	-$13.58M	-$18.00K	-$9.91M	-$10.76M	-$13.71M	-$5.64M
Free Cash Flow	-$13.20M	$35.78M	$17.57M	$5.86M	-$17.63M	$4.99M
Depreciation & Amortisation	$14.21M	$13.05M	$12.09M	$12.91M	$12.34M	$12.66M
Stock-Based Compensation	$9.31M	$5.82M	$5.82M	$3.16M	$3.69M	$1.12M
Investing Cash Flow	$181.54M	$8.79M	-$9.91M	-$9.76M	-$14.29M	-$5.64M
Financing Cash Flow	-$166.29M	$9.27M	-$26.88M	-$18.50M	-$20.40M	-$13.38M
Dividends Paid	-$3.00M	-$2.96M	-$2.96M	-$2.91M	-$2.87M	-$2.91M
Share Repurchases	-$5.01M	$0.00	-$5.01M	-$10.02M	-$5.01M	$0.00
Net Change in Cash	$15.64M	$53.86M	-$9.31M	-$11.64M	-$38.60M	-$8.39M

Market Snapshot

About

Nu Skin Enterprises, Inc. develops and distributes beauty, wellness, and personal care products through a direct selling model. The company operates globally with product lines including skincare, nutritional supplements, and anti-aging devices.